Rezolute (RZLT) Non Operating Income (2012 - 2026)
Rezolute (RZLT) recorded Non Operating Income of $1.07 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 26.6% from $1.46 million a year earlier and down 10.4% from the prior quarter.
Rezolute (RZLT) Non Operating Income (2012 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Rezolute reported Non Operating Income of $5.38 million, down 1.9% from FY2025.
- Annual Non Operating Income has a five-year compound annual growth rate of 22.0% (FY2021 to FY2026).
- Across earlier fiscal years, Non Operating Income came in at $5.48 million in FY2025 (+179.1%), $1.96 million in FY2024 (-53.3%), $4.2 million in FY2023 (+436.8%) and $783,000 in FY2022 (-60.7%).
- The fiscal Q4 2026 figure is the lowest quarterly Non Operating Income since fiscal Q4 2024.
- On a year-over-year basis, Non Operating Income rose in five of the last six quarters, with growth averaging 2.1%.
- Peak year-over-year performance for Non Operating Income in the last five years was growth of 259.2% in fiscal Q1 2024, against a decline of 91.7% in fiscal Q4 2024 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $1.2 million (Q3 2026), $1.45 million (Q2 2026) and $1.67 million (Q1 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Rezolute | 399.12 Mn | 399.12 Mn | - | 1.07 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.07 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 1.45 Mn |
| Sep 30, 2025 | 1.67 Mn |
| Jun 30, 2025 | 1.46 Mn |
| Mar 31, 2025 | 1.11 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.56 Mn |
| Jun 30, 2024 | 126,000.00 |
| Mar 31, 2024 | -837,000.00 |
| Dec 31, 2023 | 1.29 Mn |
| Sep 30, 2023 | 1.39 Mn |
| Jun 30, 2023 | 1.51 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 836,000.00 |
| Sep 30, 2022 | 387,000.00 |
| Jun 30, 2022 | 1.88 Mn |
| Mar 31, 2022 | -454,000.00 |
| Dec 31, 2021 | -444,000.00 |
| Sep 30, 2021 | -196,000.00 |
Rezolute Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=RZLT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "RZLT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=RZLT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();